Literature DB >> 2756153

Pre- and postjunctional actions of neuropeptide Y and related peptides.

E K Potter1, L Mitchell, M J McCloskey, A Tseng, A E Goodman, J Shine, D I McCloskey.   

Abstract

The effects of neuropeptide Y (NPY) and related peptide fragments on blood pressure and vagal action at the heart were compared in the anaesthetized rat. A change in vagal action was taken as a measure of presynaptic activity and a change in blood pressure was taken as a measure of postsynaptic activity. NPY, NPY-(13-36), PYY-(13-36), des-Ser22-NPY-(13-36) and a stabilized 13-36 analogue of NPY (ANA NPY) all exerted pressor actions and attenuated vagal action at the heart. The maximum vagal inhibitory or presynaptic action in order of potency was NPY, ANA-NPY, PYY-(13-36) significantly greater than NPY-(13-36), des-Ser22-NPY-(13-36). The order of potency for the half time of this effect was NPY, ANA-NPY significantly longer than PYY-(13-36) and NPY-(13-36), which were significantly longer than des Ser22-NPY-(13-36). For the pressor or postsynaptic effects, NPY increased blood pressure significantly more and for a longer duration than all the 13-36 fragments, which were not demonstrably different in this respect. These results are consistent with the proposal that there are two populations of NPY receptors. The C-terminal flanking peptide of NPY (CPON) and desamido-NPY had no effect on either vagal action at the heart or on blood pressure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2756153     DOI: 10.1016/0167-0115(89)90258-9

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  10 in total

1.  Modulation of sympathetic neurotransmission by neuropeptide Y Y2 receptors in rats and guinea pigs.

Authors:  Erica K Potter; Diana Tripovic
Journal:  Exp Brain Res       Date:  2006-05-30       Impact factor: 1.972

2.  Tyrosine hydroxylase- and neuropeptide Y-immunoreactive nerve fibers in the pineal complex of untreated rats and rats following removal of the superior cervical ganglia.

Authors:  E T Zhang; J D Mikkelsen; M Møller
Journal:  Cell Tissue Res       Date:  1991-07       Impact factor: 5.249

3.  Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.

Authors:  A P Serone; C E Wright; J A Angus
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  The effects of neuropeptide Y and its fragments upon basal and electrically stimulated ion secretion in rat jejunum mucosa.

Authors:  H M Cox; A W Cuthbert
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

5.  Neuropeptide Y inhibits Ca2+ influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor.

Authors:  D Bleakman; W F Colmers; A Fournier; R J Miller
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

6.  Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions.

Authors:  M A Smith-White; T A Hardy; J A Brock; E K Potter
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

7.  Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse.

Authors:  Margaret A Smith-White; Tiina P Iismaa; Erica K Potter
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

8.  Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain.

Authors:  J Xia; T O Neild; N Kotecha
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

9.  Neuropeptide Y receptors: how to get subtype selectivity.

Authors:  Xavier Pedragosa-Badia; Jan Stichel; Annette G Beck-Sickinger
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-04       Impact factor: 5.555

Review 10.  Regulation of neuropeptide Y in body microenvironments and its potential application in therapies: a review.

Authors:  Yan Zhang; Chu-Yun Liu; Wei-Can Chen; Yan-Chuan Shi; Cong-Mei Wang; Shu Lin; He-Fan He
Journal:  Cell Biosci       Date:  2021-08-03       Impact factor: 7.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.